Physician profile
Kathy Williams
NPI 1811491954
$3,751.65
in general payments reported to CMS, 2019-2025
14 companies · $581 in 2025
The $581 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.75 · 2022: $249 · 2023: $513 · 2024: $2,349 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,381 · Travel and Lodging: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,381.32 |
| Travel and Lodging | $1,062.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $1,346.08 | 2024-2025 | Cologuard Collection Kit |
| Janssen Scientific Affairs, LLC | $712.74 | 2022-2024 | Stelara, Tremfya |
| Janssen Biotech, INC. | $388.91 | 2023-2024 | Stelara |
| Conmed Corporation | $340.00 | 2024 | Conmed Biliary, Conmed Hemostasis, Conmed Dilation |
| Abbvie INC. | $313.64 | 2022-2025 | Skyrizi |
| Gilead Sciences, INC. | $250.99 | 2024-2025 | Livdelzi |
| Takeda Pharmaceuticals U.S.A., INC. | $135.95 | 2022-2025 | Entyvio, Eohilia |
| E.R. Squibb & Sons, L.L.C. | $103.82 | 2023 | |
| Lilly USA, LLC | $59.75 | 2021 | |
| Mallinckrodt Hospital Products INC. | $27.46 | 2023 | Terlivaz |
| Genzyme Corporation | $18.93 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.63 | 2024 | Dupixent |
| Celltrion USA INC. | $17.47 | 2025 | Vegzelma |
| Olympus America INC. | $17.28 | 2025 | Single Use Repositionable Clip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.